放射肿瘤学市场报告：趋势、预测和竞争分析（至 2031 年）

由于摄护腺癌、乳癌、肺癌、大肠直肠癌和子宫颈癌市场存在机会，全球放射治疗市场的未来前景光明。预计到 2031 年全球放射治疗市场规模将达到 113 亿美元，2025 年至 2031 年的复合年增长率为 5.9%。该市场的主要驱动因素是癌症发生率的增加、放射治疗技术的进步以及老年人口的增加。

• 根据 Lucintel 的预测，基于类型，外部放射线治疗预计将成为预测期内最大的细分市场。这是因为，将辐射精确地引导至癌细胞，使得肿瘤学家能够使用更高剂量的放射线治疗进行治疗，同时对正常组织造成更少的损害。
• 根据应用，前列腺癌预计将继续成为最大的细分市场，因为前列腺癌的发生率不断增加，且与其他类型的癌症相比成功率更高。
• 根据地区划分，预计亚太地区将在预测期内实现最高增长，这得益于该地区人们对放射治疗认识的不断提高、医疗保健支出的不断增加以及老年人口的不断增长。

放射肿瘤学市场的策略性成长机会

随着新应用和新技术的出现，治疗的广度和深度不断增加，放射治疗市场在未来几年具有巨大的成长潜力。癌症发生率不断上升，需要先进的治疗以及更有针对性的治疗方法，这为各种应用创造了策略性成长机会。

• 质子治疗中心扩建：质子治疗中心扩建是放射治疗产业一个有吸引力的成长机会。随着质子治疗的副作用更少、标靶性更高等优点得到越来越广泛的认可，对质子治疗的需求也日益增加。世界各地正在建立新的质子治疗中心，特别是在美国等无法获得晚期癌症治疗的国家。因此，放射治疗市场的成长预计将受到质子治疗日益普及的推动，这将使更多人能够负担得起质子治疗的成本并提高其接受度。
• 个人化治疗中人工智慧的应用成长：市场对利用人工智慧进行临床放射治疗规划的兴趣日益浓厚。人工智慧可以评估许多变量，从而可以创建个人化的治疗方法，最大限度地提高疗效并最大限度地减少副作用。随着人工智慧的发展，放射治疗的应用范围将不断扩大，预计治疗效果和患者照护将进一步改善。这一趋势正在刺激基于人工智慧的新产品和软体的成长，它们很可能在未来的放射肿瘤学市场中发挥核心作用。
• 扩大低分次放射治疗：随着临床医师和患者寻求更好、更快的治疗方法，低分次放射治疗的应用不断扩大。低分次放射治疗可在较短时间内完成治疗，从而减轻医疗系统的负担并改善患者体验。这对于癌症治疗尤其有利，因为癌症治疗需要在短时间内释放高剂量的辐射。

随着低分次放射治疗越来越被采用，预计市场将会扩大，因为它是一种低成本、低侵入性的治疗方法，特别是对于患有多种健康问题的人。

• 新兴市场的放射肿瘤学扩张：新兴市场为放射肿瘤学服务的成长提供了巨大的机会。这些地区拥有发达的医疗保健基础设施，对包括放射治疗在内的先进癌症治疗的需求日益增长。新兴市场政府和私人医疗部门正在大力投资建造放射治疗中心和实施最新技术。此次扩张预计将为全球更多的患者提供先进的癌症治疗，从而支持放射治疗市场。随着这些新兴市场不断发展，它们很可能在整个放射肿瘤学市场的成长和发展中发挥关键作用。

放射治疗市场的策略成长机会包括新质子治疗中心的开设、人工智慧在个人化治疗中的整合、低分次放射治疗的扩展、新兴经济体的成长以及与免疫疗法的合作以显着改善癌症治疗。针对这些机会的策略不仅扩大了放射治疗的范围，而且还提高了其疗效并改善了患者的治疗效果。预计此类变化将在不久的将来发生，并将影响放射治疗市场的成长，旨在更有效地为更多患者提供个人化的癌症管理治疗。

放射肿瘤学市场驱动因素与挑战

放射治疗市场受到技术发展、经济因素和法规交互作用的影响。虽然这些方面刺激了创新和市场扩张，但也带来了重大挑战，必须解决才能避免停滞。主要驱动因素包括癌症患者数量的增加、放射治疗技术的改进、对医疗费用的支持、对放射治疗认识的不断提高以及政府加强癌症治疗的计划。

推动放射治疗市场成长的因素有：

• 癌症发生率上升：癌症发生率上升：全球癌症患者数量的增加是放射治疗市场发展的主要驱动力。由于人口老化和生活方式因素导致癌症风险增加，对有效治疗方案的需求日益增加。随着生活方式改变、人口老化和环境影响等各种因素导致癌症患者数量增加，放射治疗的需求变得更加突出。
• 技术进步：放射技术的快速进步，例如质子治疗、MR-linac 系统和 AI 整合的发展，正在提高放射治疗的有效性和效率。这些技术使治疗更安全、更精确，更多患者也更容易接受。
• 政府承诺和资金：政府正在增加对医疗保健倡议的投资，旨在改善癌症护理基础设施并扩大放射治疗的机会。这些倡议提高了人们对治疗中心的认识和可用性，为市场成长做出了巨大贡献。
• 患者的认知和接受度：随着对癌症治疗和放射治疗益处的认识不断提高，越来越多的患者接受治疗。这种观念的转变对市场需求产生了正面影响。

阻碍放射肿瘤学市场成长的挑战是：

• 设备和治疗成本不断上涨：先进放射治疗设备的初始安装成本高昂，这可能会使一些医疗机构（尤其是新兴市场的医疗机构）难以采用新技术。高昂的费用可能会限制人们获得现代放射治疗的选择。
• 训练有素的专业人员短缺：合格的放射肿瘤学家、医学物理学家和其他训练有素的人员的短缺会阻碍先进放射治疗技术的有效实施。这种差距可能会延迟患者获得护理的机会并影响治疗结果。
• 监管挑战：放射治疗产业必须适应各国不同的复杂监管环境。遵守严格的法规可能会导致产品上市延迟，并增加引入新技术的成本。
• 病患特定因素：个别病患的健康状况和遗传倾向可能会影响治疗结果。了解这些因素对于个人化放射治疗至关重要，但在治疗通讯协定中充分解决这些因素仍有挑战。

总之，放射肿瘤学市场虽然受到多种成长要素的推动，但也面临重大挑战。平衡这些因素是推动该领域发展和确保患者接受最有效和最容易获得的治疗的关键。

目录

第一章执行摘要

第 2 章全球放射肿瘤学市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球放射肿瘤学市场趋势（2019-2024 年）与预测（2025-2031 年）
• 全球放射治疗市场按类型
  • 外部放射治疗
  • 体内放射疗法
  • 全身放射线治疗
• 全球放射肿瘤学市场（按应用）
  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 大肠直肠癌
  • 子宫颈癌
  • 其他的
• 全球放射肿瘤学市场（按最终用途划分）
  • 医院
  • 独立放射治疗中心
  • 其他的

第 4 章。

• 全球放射肿瘤学市场（按地区）
• 北美放射肿瘤学市场
• 欧洲放射治疗市场
• 亚太地区放射肿瘤学市场
• 世界其他地区的放射治疗市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球放射肿瘤学市场成长机会（按类型）
  • 全球放射肿瘤学市场的成长机会（按应用）
  • 全球放射肿瘤学市场成长机会（依最终用途划分）
  • 全球放射肿瘤学市场各区域成长机会
• 全球放射治疗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球放射治疗市场容量不断扩大
  • 全球放射肿瘤学市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业公司简介

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

The future of the global radiotherapy market looks promising with opportunities in the prostate cancer, breast cancer, lung cancer, colorectal cancer, and cervical cancer markets. The global radiotherapy market is expected to reach an estimated $11.3 billion by 2031 with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the increasing cancer incidence, advancements in radiotherapy technology, and the growing geriatric population.

• Lucintel forecasts that, within the type category, external beam radiation therapy will remain the largest segment over the forecast period due to the accuracy of the direct beams at the cancerous cells, which results in less damage to normal tissues, while allowing oncologists to use higher doses of radiotherapy for treatment.
• Within the application category, prostate cancer will remain the largest segment due to the growing incidence of prostate cancer and higher success rate as compared to other cancer types.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growing awareness about radiotherapy, rising healthcare expenditure, and increasing geriatric population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Radiotherapy Market

The phenomenon and trends prevailing in the radiotherapy market are changing for the better due to technological advancements, changing healthcare needs, and the search for more efficient ways to treat cancer. New developments in this area, expanding beyond the limited view of seeking only cancer cures, are improving not only the effectiveness of radiotherapy but also reinforcing its use in a greater variety of cancers and for more patients. As healthcare institutions and practitioners remain innovative, it is safe to say that these trends will transform the cancer care sector for the better by providing more treatment options and offering greater hope to patients.

• Proton Therapy Expansion: Proton therapy is emerging as one of the leading approaches in the treatment of specific tumor types, especially those located close to critical organs such as the brain and spinal cord. This trend stems from the fact that high doses of radiation can be delivered within a shorter distance from the tumor while inflicting less or no damage to normal tissue. Several proton therapy facilities are being established globally, thereby increasing the accessibility of advanced treatment to a growing pool of patients. More facilities and manpower are expected to be developed for the administration of proton therapy, further diversifying the radiotherapy industry and improving outcomes.
• Integration of Artificial Intelligence (AI): Artificial intelligence is changing the landscape of the radiotherapy market by increasing the precision and speed of treatment planning and delivery. Complex images are analyzed, the optimal radiation dose is determined, and the outcomes for each patient are predicted as accurately as possible, thanks to specially developed AI algorithms. This approach is also helping to shorten the treatment planning phase, reducing the waiting period for patients before treatment commences. Improvements in AI will enhance integration in radiotherapy, with expectations for greater precision in treatments, fewer adverse effects, and better results for patients.
• Increasing Use of Image-Guided Radiotherapy (IGRT): Recently, there has been a significant advent of new technology in Image-Guided Radiotherapy (IGRT). IGRT includes the availability of live images, such as Computed Tomography (CT) or MRI-guided tumor volume imaging, during radiotherapy delivery. This allows for adjustments during treatment to accommodate tumor movements or patient repositioning. The increasing use of IGRT is enhancing treatment accuracy, lowering unintended radiation doses to patients, and improving the prospects of radiation therapy for more types of cancer.
• Combination of Radiotherapy with Immunotherapy: Integrating radiotherapy with immunotherapy is a new trend that has high potential and will improve outcomes in cancer treatment. Immunotherapy enhances the body's immune response to detect and address cancerous tissues, complementing radiotherapy that involves radiation exposure. This combination treatment strategy is effective for cancers that do not respond to conventional treatment approaches. Research is ongoing, and clinical trials are underway to establish the best combinations and sequences of such treatments to ensure their maximal effect and broaden their clinical applications.

Newly developed concepts within the radiotherapy market, such as management of proton therapy by centers, incorporation of AI, the rise in application of IGRT, combination with immunotherapy, and individualization of treatment, stand to change the narrative around cancer treatment. These improvements are not just augmenting the accuracy and efficacy of radiotherapy techniques; they are also expanding the scope of radiotherapy usage for more patients with various oncological diseases. As these trends advance, they are poised to propel the growth of the radiotherapy market and improve the prognosis for patients diagnosed with cancer worldwide.

Recent Developments in the Radiotherapy Market

The radiotherapy market is inundated with new technologies, approved regulations, and increasing investment interest due to cancer treatments. All these developments aim to enhance the quality of radiotherapy treatments and improve patient outcomes. As the demand for advanced cancer therapies increases, the thermotherapy market is expanding, showcasing advanced techniques and equipment to develop individualized therapies targeting specific ailments.

• Advancement in Proton Therapy: Proton therapy has developed significantly and has emerged as a breakthrough in the radiotherapy market, as it offers better chances of targeting tumor regions without harming healthy tissues. Recently, efforts have focused on making proton therapy more viable and addressing existing limitations in the number of centers offering this therapy due to high costs. These trends encourage the use of proton therapy for many more malignancies, even those currently treated solely with surgical methods or those resistant to conventional radiotherapy. The rise in the availability of proton therapy services is anticipated to have substantial potential in the radiotherapy market by reaching more patients.
• Integration of Artificial Intelligence in Treatment Planning: The use of artificial intelligence (AI) in the planning of radiotherapy treatments is changing the market for the better by increasing the efficiency and accuracy of treatment protocols. Recently, AI is being applied to manage patient information, optimize radiation doses, and predict outcomes. This evolution not only shortens the duration of treatment planning but also facilitates greater individualization in treatment approaches. Continued advancements in AI will further enhance its effectiveness in radiotherapy, contributing to market growth.
• Expansion of Stereotactic Body Radiotherapy (SBRT): Stereotactic Body Radiotherapy (SBRT) is quickly becoming the conventional option for managing specific types of cancer, particularly carcinomas of the lung, liver, and spine. Delivery of SBRT typically occurs in three to five treatment sessions rather than the numerous fractions traditionally offered, resulting in fewer complications compared to surgical approaches. The last decade has focused on improving SBRT modalities, refining patient selection, and broadening its application for additional oncological indications. Given the clinically satisfactory results achieved, the market for these systems is expected to grow as more patients seek effective yet less harmful treatment through SBRT.
• Development of MR-Linac Technology: The advancement of Magnetic Resonance Linear Accelerator (MR-Linac) technology represents a revolutionary advance in radiation oncology. MR-Linac allows for tumor visualization while directing radiation, leveraging the benefits of MRI and the linear accelerator. This technology enhances radiation delivery to the tumor and allows for adjustments based on tumor movement, making treatment more effective and minimizing side effects. The emergence of MR-Linac technology improves the effectiveness of radiotherapy for complex and mobile tumors, thus positively contributing to the growth of the radiotherapy market.

Recent trends in the radiotherapy market, such as the advent of proton therapy, incorporation of artificial intelligence, expansion of SBRT, MR-Linac technology, and hypofractionated radiotherapy, are transforming cancer treatment. These developments are not only increasing the accuracy and efficacy of radiotherapy but also enhancing the affordability and convenience of this treatment.

Strategic Growth Opportunities for Radiotherapy Market

There is substantial growth potential in the radiotherapy market in the coming years as new applications and technologies emerge, enhancing the breadth and depth of therapies. Strategic growth opportunities are arising in different applications due to the rising incidence of cancer requiring advanced treatment alongside more targeted approaches.

• Expansion of Proton Therapy Centers: The expansion of proton therapy centers presents an attractive growth opportunity in the radiotherapy industry. Demand for such therapy is increasing as the advantages of proton therapy, such as lower side effects and higher targeting precision, become more recognized. New proton therapy centers are being established worldwide, especially in countries where advanced cancer treatments are limited, such as in the US. Therefore, it is predicted that the growth of the radiotherapy market will be driven by increased proton therapy usage, making it affordable to a larger population and encouraging its acceptance.
• Growth in the Use of AI for Personalized Treatment: There is growing market interest in utilizing AI for clinical radiation therapy planning. AI can evaluate many variables, allowing for the creation of individualized therapies that maximize efficacy and minimize adverse effects. Continued developments in AI will lead to broader applications in radiotherapy, further improving the effectiveness of procedures and patient care. This trend is fueling the growth of new AI-based products and software that are likely to play a central role in the future of the radiotherapy market.
• Expansion of Hypofractionated Radiotherapy: The use of hypofractionated radiotherapy continues to grow as clinicians and patients seek better and faster treatment methods. Hypofractionation involves delivering treatment over a shorter period, easing the burden on the healthcare system and improving patient experience. This is particularly favorable for treating cancers with shorter, higher radiation doses.

With the increasing adoption of hypofractionated radiotherapy, market expansion is anticipated, as this is a low-cost and less cumbersome treatment option, especially for populations with diverse health concerns.

• Radiotherapy Expansion in Emerging Markets: Emerging markets offer significant opportunities for the growth of radiotherapy services. With improvements in healthcare infrastructure in these regions, the demand for advanced cancer therapies, including radiotherapy, is rising. Governments and private health sectors in emerging markets are investing heavily in building radiotherapy centers and deploying modern technology. This escalation is expected to support the radiotherapy market by providing advanced cancer treatment to more patients than ever before on a global scale. As these markets continue to develop, they are likely to play a vital role in the overall growth and development of the radiotherapy market.

Strategic growth opportunities in the radiotherapy market are being driven by the establishment of new proton therapy centers, the integration of artificial intelligence in personalized treatment, the expansion of hypofractionated radiotherapy, growth in developing economies, and collaboration with immunotherapy to significantly improve cancer treatment. Strategies targeting these opportunities are not just widening the scope of radiotherapy; they are also enhancing its efficacy and improving patient outcomes. These changes are anticipated to develop in the near future and will influence the growth of the radiotherapy market toward delivering personalized cancer management therapies efficiently to more patients.

Radiotherapy Market Driver and Challenges

The radiotherapy market is shaped by the interplay between technological development, economic factors, and regulations. These aspects spur innovation and market expansion while also presenting significant challenges that need to be addressed to avoid stagnation. Key drivers include the rise in cancer cases, technological improvements in radiation therapy, support for healthcare costs, increased awareness of radiotherapy treatments, and government cancer treatment enhancement programs.

The factors responsible for driving the growth of the radiotherapy market are:

• Rising Cancer Incidence: The global increase in cancer cases is a significant driver of the radiotherapy market. With an aging population and lifestyle factors contributing to cancer risk, the demand for effective treatment options is escalating. As cancer cases rise due to various factors like lifestyle changes, population aging, and environmental influences, the need for radiotherapy becomes more pronounced.
• Technological Advancements: Rapid advancements in radiation technology, such as the development of proton therapy, MR-Linac systems, and AI integration, are enhancing the effectiveness and efficiency of radiotherapy. These technologies are making treatments safer, more accurate, and accessible to a broader patient population.
• Government Initiatives and Funding: Governments are increasingly investing in healthcare initiatives aimed at improving cancer treatment infrastructure and expanding access to radiotherapy. These initiatives contribute significantly to market growth by enhancing awareness and increasing the number of available treatment centers.
• Patient Awareness and Acceptance: The growing awareness of cancer treatments and the benefits of radiotherapy is encouraging more patients to seek treatment. This shift in perception is positively influencing market demand.

However, the radiotherapy market faces challenges that may impede growth, including:

• High Costs of Equipment and Treatment: The initial setup costs for advanced radiotherapy equipment are substantial, making it difficult for some healthcare facilities, especially in emerging markets, to adopt new technologies. This high expense can limit access to modern radiotherapy options.
• Shortage of Trained Professionals: A shortage of qualified radiation oncologists, medical physicists, and other trained personnel may hinder the effective implementation of advanced radiotherapy techniques. This gap can delay patient access to treatment and affect outcomes.
• Regulatory Challenges: The radiotherapy industry must navigate complex regulatory landscapes, which can vary by country. Compliance with stringent regulations may lead to delays in product launches and increase the costs associated with new technology adoption.
• Patient-Specific Factors: Individual patient health conditions and genetic predispositions can influence treatment outcomes. Understanding these factors is essential for personalizing radiotherapy, yet challenges remain in adequately addressing them within treatment protocols.

In conclusion, while the radiotherapy market is driven by several growth factors, it also faces significant challenges. Balancing these elements is critical for advancing the field and ensuring patients receive the most effective and accessible treatments possible.

List of Radiotherapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiotherapy companies profiled in this report include-

• Ion Beam Applications
• Elekta
• Accuray Incorporated
• Isoray
• Becton
• Dickinson and Company
• Siemens Healthineers
• ICAD
• Nordion
• MEVION MEDICAL SYSTEMS

Radiotherapy by Segment

The study includes a forecast for the global radiotherapy market by type, application, end use, and region

Radiotherapy Market by Type [Analysis by Value from 2019 to 2031]:

• External Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiation Therapy

Radiotherapy Market by Application [Analysis by Value from 2019 to 2031]:

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

Radiotherapy Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Independent Radiotherapy Centers
• Others

Radiotherapy Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Radiotherapy Market

Here's the revised content without single line spaces between sentences, except for headings:

The radiotherapy market is growing at a rapid pace in all parts of the world owing to technological developments, the surge in the number of cancer patients, and the improvement in the status of healthcare services. With the growing recognition of the need for better healthcare, nations are now embracing new methods of radiotherapy and increasing the reach of these services. This growth in demand is additionally attributed to the incorporation of artificial intelligence and precision medicine into the practice of radiotherapy, which increases its effectiveness and safety.

• United States: Among some of the more recent changes in the radiotherapy industry in the United States is the quick adoption of advanced technologies, including proton therapy and SBRT. These modes allow for very precise delivery of radiation to the tumor with minimal damage to the surrounding healthy tissues. Further, the use of artificial intelligence in the treatment planning and delivery mechanisms has boosted the efficiency of radiotherapy, generating commendable results in patients. Finally, the US market is also committing itself to further investments that widen the scope of provision of radiotherapy services, for example, in terms of geography to include rural and clinically underserved regions, in both government and private initiatives.
• China: The radiotherapy market in China is also growing rapidly due to increasing cases of cancer, as well as considerable governmental investments in the healthcare system. Recent developments include improved control of x-ray treatment, where IMRT and IGRT techniques are extensively utilized. Besides, there is considerable activity in the form of building more cancer treatment centers with the best available radiotherapy equipment in China. Collaborations between Chinese institutes and foreign healthcare corporations will also help in the transfer of newer radiotherapy methods and technologies back to China so that it can provide more advanced cancer therapy.
• Germany: * Within the German market of radiotherapy, one has to admit that the country's healthcare is gradually leaning towards models of precision medicine, as well as models that advocate for personalized treatment in generic radiotherapy. Trends such as the growing popularity of using molecular imaging techniques together with radiotherapy to target tumor cells while sparing normal tissues are also underway. Germany is involved in examining strategies that combine radiotherapy with immunotherapy, thereby widening the possibilities for the immune response to tumors. Additionally, the country is working on eliminating geographic barriers for radiotherapy services by increasing the number of specialized centers and adopting state-of-the-art radiotherapy equipment.
• India: There has been significant development in the radiotherapy market in India due to increased awareness, government participation, and public-private partnerships in the cancer treatment sector. This development has led to more complex models evolving in payment structures, which intensify the introduction of advanced radiotherapy methods in cancer hospitals, such as stereotactic radiosurgery (SRS) or brachytherapy. There is also an increased focus on training, education, and orientation of personnel so that professionals can utilize modern radiotherapy technologies. Additionally, there is geographical imbalance in radiotherapy availability. New centers are being created in underserved areas to reduce disparities in cancer treatment across the country.
• Japan: The Japanese radiotherapy market is on an upward trajectory due to the incorporation of newer treatment techniques, including drug delivery using protons and heavy ions for distant and difficult-to-operate tumors. Recent developments also include the use of AI and machine learning in treatment planning, wherein the targeting dose is further improved. Efforts are being made to develop the radiotherapy infrastructure in Japan, with new cancer treatment facilities being built in response to the rising demand for modern cancer treatment services. In addition, there is a greater focus on research and development in the area of radiotherapy, with studies currently being undertaken to combine conventional forms of treatment with others, such as immunotherapy.

Features of the Global Radiotherapy Market

Market Size Estimates: Radiotherapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Radiotherapy market size by type, application, and region in terms of value ($B).

Regional Analysis: Radiotherapy Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the radiotherapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiotherapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the radiotherapy market by type (external beam radiation therapy, internal radiation therapy, and systemic radiation therapy), application (prostate cancer, breast cancer, lung cancer, colorectal cancer, cervical cancer, and others), end use (hospitals, independent radiotherapy centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radiotherapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Radiotherapy Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Radiotherapy Market by Type
  • 3.3.1: External Beam Radiation Therapy
  • 3.3.2: Internal Radiation Therapy
  • 3.3.3: Systemic Radiation Therapy
• 3.4: Global Radiotherapy Market by Application
  • 3.4.1: Prostate Cancer
  • 3.4.2: Breast Cancer
  • 3.4.3: Lung Cancer
  • 3.4.4: Colorectal Cancer
  • 3.4.5: Cervical Cancer
  • 3.4.6: Others
• 3.5: Global Radiotherapy Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Independent Radiotherapy Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Radiotherapy Market by Region
• 4.2: North American Radiotherapy Market
  • 4.2.1: North American Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.2.2: North American Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.3: European Radiotherapy Market
  • 4.3.1: European Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.3.2: European Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.4: APAC Radiotherapy Market
  • 4.4.1: APAC Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.4.2: APAC Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others
• 4.5: ROW Radiotherapy Market
  • 4.5.1: ROW Market by Type: External Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiation Therapy
  • 4.5.2: ROW Market by Application: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Radiotherapy Market by Type
  • 6.1.2: Growth Opportunities for the Global Radiotherapy Market by Application
  • 6.1.3: Growth Opportunities for the Global Radiotherapy Market by End Use
  • 6.1.4: Growth Opportunities for the Global Radiotherapy Market by Region
• 6.2: Emerging Trends in the Global Radiotherapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Radiotherapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiotherapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ion Beam Applications
• 7.2: Elekta
• 7.3: Accuray Incorporated
• 7.4: Isoray
• 7.5: Becton
• 7.6: Dickinson and Company
• 7.7: Siemens Healthineers
• 7.8: ICAD
• 7.9: Nordion
• 7.10: MEVION MEDICAL SYSTEMS